JPS6241224B2 - - Google Patents

Info

Publication number
JPS6241224B2
JPS6241224B2 JP53142813A JP14281378A JPS6241224B2 JP S6241224 B2 JPS6241224 B2 JP S6241224B2 JP 53142813 A JP53142813 A JP 53142813A JP 14281378 A JP14281378 A JP 14281378A JP S6241224 B2 JPS6241224 B2 JP S6241224B2
Authority
JP
Japan
Prior art keywords
group
phenyl
lower alkyl
alkyl group
antidepressant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53142813A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5569567A (en
Inventor
Motosuke Yamanaka
Isao Saito
Kyomi Yamatsu
Masako Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP14281378A priority Critical patent/JPS5569567A/ja
Priority to US06/093,469 priority patent/US4301169A/en
Priority to GB7939283A priority patent/GB2044754B/en
Priority to SE7909371A priority patent/SE447653B/sv
Priority to CA339,861A priority patent/CA1126272A/en
Priority to IT27268/79A priority patent/IT1127223B/it
Priority to NL7908331A priority patent/NL7908331A/nl
Priority to FR7928099A priority patent/FR2441616B1/fr
Priority to DE19792946020 priority patent/DE2946020A1/de
Priority to CH1014979A priority patent/CH642635A5/fr
Publication of JPS5569567A publication Critical patent/JPS5569567A/ja
Priority to US06/252,674 priority patent/US4402966A/en
Priority to US06/469,548 priority patent/US4533669A/en
Priority to US06/741,935 priority patent/US4602031A/en
Publication of JPS6241224B2 publication Critical patent/JPS6241224B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14281378A 1978-11-14 1978-11-21 Novel imidazole compound, and antidepressant containing the same Granted JPS5569567A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP14281378A JPS5569567A (en) 1978-11-21 1978-11-21 Novel imidazole compound, and antidepressant containing the same
US06/093,469 US4301169A (en) 1978-11-14 1979-11-13 Novel imidazole compound and anti-depressing agent containing the same
GB7939283A GB2044754B (en) 1978-11-14 1979-11-13 Imidazoles
SE7909371A SE447653B (sv) 1978-11-14 1979-11-13 Imidazolderivat samt farmaceutisk komposition innehallande sadant derivat
FR7928099A FR2441616B1 (fr) 1978-11-14 1979-11-14 Nouvel imidazole, procede pour sa preparation et son application therapeutique
IT27268/79A IT1127223B (it) 1978-11-14 1979-11-14 Composto dell'imidazolo e medicamento contro gli stati depressivi contenente detto composto
NL7908331A NL7908331A (nl) 1978-11-14 1979-11-14 Imidazoolderivaten met anti-depressieve werking.
CA339,861A CA1126272A (en) 1978-11-14 1979-11-14 Imidazole compound and anti-depressing agent containing the same
DE19792946020 DE2946020A1 (de) 1978-11-14 1979-11-14 Imidazolverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH1014979A CH642635A5 (fr) 1978-11-14 1979-11-14 Derives de l'imidazole, procedes pour leur preparation et compositions medicamenteuses contenant ces derives.
US06/252,674 US4402966A (en) 1978-11-14 1981-04-09 Acylaminophenyl imidazoles and anti-depressing agent containing the same
US06/469,548 US4533669A (en) 1978-11-14 1983-02-25 Anti-depressant imidazoles
US06/741,935 US4602031A (en) 1978-11-14 1985-06-06 Anti-depressant imidazoles, compositions and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14281378A JPS5569567A (en) 1978-11-21 1978-11-21 Novel imidazole compound, and antidepressant containing the same

Publications (2)

Publication Number Publication Date
JPS5569567A JPS5569567A (en) 1980-05-26
JPS6241224B2 true JPS6241224B2 (enrdf_load_stackoverflow) 1987-09-02

Family

ID=15324215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14281378A Granted JPS5569567A (en) 1978-11-14 1978-11-21 Novel imidazole compound, and antidepressant containing the same

Country Status (1)

Country Link
JP (1) JPS5569567A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2352295A (en) * 1994-04-27 1995-11-16 Nippon Soda Co., Ltd. Imidazole derivative and process for producing the same
EP1614684B8 (en) 2003-04-14 2009-08-05 Nippon Soda Co., Ltd. Diamine derivative, production process, and antioxidizing drug
WO2005012293A1 (ja) 2003-08-01 2005-02-10 Nippon Soda Co., Ltd. フェニルアゾール化合物、製造法および抗酸化薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160097A (en) * 1977-01-07 1979-07-03 Westwind Pharmaceuticals, Inc. 1-(2-Phenylureylene)imidazoles

Also Published As

Publication number Publication date
JPS5569567A (en) 1980-05-26

Similar Documents

Publication Publication Date Title
US4533669A (en) Anti-depressant imidazoles
EP1302461B1 (en) Tnf-alpha production inhibitors
US20250002449A1 (en) Compositions of essentially pure form iv of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
JP2017523972A (ja) Ｆｌｔ３レセプターアンタゴニスト
BR112020022738A2 (pt) formas cristalinas de um inibidor tlr7/tlr8
JPH0224821B2 (enrdf_load_stackoverflow)
KR850000216B1 (ko) 피페라진 유도체의 제조방법
KR0150649B1 (ko) 술폰아닐리드 유도체 및 의약
KR930001835B1 (ko) 신규 히단토인(Hydantoin) 유도체의 제조방법
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
CA3201608A1 (en) Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof
US6664267B1 (en) Crystalline fluoroquinolone arginine salt form
JPS6241224B2 (enrdf_load_stackoverflow)
TW201718590A (zh) 化合物
CH648283A5 (fr) Acides 2-amino-3-(alpha-hydroxybenzyl)-phenylacetiques et sels metalliques, esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant.
IL304974A (en) Preparations of mainly pure configuration IV of N-((R)-3,2-dihydroxypropoxy)-4,3-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and their uses
CN112759545B (zh) 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途
ES2281827T3 (es) Sales de tartrato de 2-metoximetil-3-(3,4-diclorofenil)-8-azabiciclo(3.2.1)octano.
CN106916104B (zh) 用于治疗结肠炎的药物
CN112759546B (zh) 3-(二甲氨基甲基)哌啶-4-醇衍生物及其制备方法和药物用途
CN112759538B (zh) 3-(二甲氨基甲基)环己-4-醇衍生物及其制备方法和药物用途
EP0187639B1 (en) Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient
JPH05508170A (ja) 新規なジフルオロキノロンと、その合成方法と、それを含む医薬
JPS6140227B2 (enrdf_load_stackoverflow)
JPH02237928A (ja) 置換ベンズアミドより成る胃の自動運動性増進用薬剤